Structure–activity studies at the rat tachykinin NK2 receptor: effect of substitution at position 5 of neurokinin A
- 1 March 1999
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 53 (3) , 337-342
- https://doi.org/10.1034/j.1399-3011.1999.00038.x
Abstract
A series of analogues of neurokinin A(4–10) was synthesized using solid phase techniques with Chiron pins, and purified by HPLC. The potencies of 10 peptides with substitution at Ser5 were assessed at rat fundus NK2 receptors. In membrane binding studies with [125I]‐[Lys5,Tyr(I2)7,MeLeu9,Nle10]‐NKA(4–10), all compounds except [Asp5]NKA(4–10) showed reasonable affinity, and analogues with Lys and Arg substitutions were five‐fold more potent than NKA(4–10). In functional studies, all peptides were able to contract the rat isolated fundus strips. Analogues with Phe, His and Asn substitutions were substantially weaker in functional than in binding studies, whereas there was an excellent correlation (r = 0.95) between binding and functional potency for the remaining seven peptides. [Phe5]NKA(4–10) is in fact neurokinin B(4–10) and this residue may be critical in determining selectivity between NK2 and NK3 receptors. Analogues with a basic residue (Lys, Arg) at position 5 showed both increased affinity and functional potency, whereas the neutral [Asn5]NKA(4–10) was equally as weak in contractile studies as the acidic [Asp5]NKA(4–10). However, [Glu5]NKA(4–10) and [Gln5]NKA(4–10) were no different from NKA(4–10). Our results could indicate the presence of a negative charge on the NK2 receptor, close to position 5 of NKA. This would facilitate interaction with positively charged side chains and impede interaction with negatively charged side chains, particularly the inflexible side chain of aspartic acid. Thus, not only the charge, but also the length of the side chain of the residue at position 5, seems to be important for interaction with the rat NK2 receptor.Keywords
This publication has 10 references indexed in Scilit:
- Probing the Binding Domain of the NK2 Receptor with Fluorescent Ligands: Evidence That Heptapeptide Agonists and Antagonists Bind DifferentlyBiochemistry, 1995
- Locating ligand-binding sites in 7tm receptors by protein engineeringCurrent Opinion in Biotechnology, 1994
- Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.Published by Elsevier ,1993
- Characterisation of a novel, selective radioligand, [125I][Lys5,Tyr(I2)7,MeLeu9,Nle10]neurokinin A-(4–10), for the tachykinin NK2 receptor in rat fundusEuropean Journal of Pharmacology, 1993
- Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.Journal of Biological Chemistry, 1992
- Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay)Neuropeptides, 1991
- Structure-activity studies of neurokinin ANeuropeptides, 1989
- Selective agonists for receptors of substance P and related neurokininsBiopolymers, 1989
- Selective agonists for substance P and neurokinin receptorsPublished by Elsevier ,1987
- Tachykinin antagonist. I: Specific, competitive and tissue-selective neurokinin B antagonists on contractile activity in smooth muscles.The Japanese Journal of Pharmacology, 1987